CSIMarket
 
Stereotaxis Inc   (NYSEAMER: STXS)
 

Stereotaxis Inc's Suppliers Performance

STXS's Supply Chain




 
STXS Costs vs Sales of Suppliers Growth Stereotaxis Inc's cost of sales deteriorated by -20.4 % year on year, sequentially cost of sales grew by 59.2 % in Q2.

More on STXS Suppliers



Stereotaxis Inc's cost of sales deteriorated by -20.4 % year on year, sequentially cost of sales grew by 59.2 % in Q2.

More on STXS Suppliers




Stereotaxis Inc's Comment on Supply Chain


The company subcontracts all or part of the manufacturing and assembly of components for its products and devices. It faces risks including quality issues and manufacturing delays at its own facilities or those of subcontractors, which could affect revenue. The company may need to improve or modify product designs or subcontractor production processes to meet customer performance requirements. Efforts to upgrade and expand manufacturing, assembly, and testing capabilities may involve substantial costs and unexpected delays. The company recently completed the acquisition of APT, which previously operated independently and produced different products. Successful integration of APT depends on manufacturing, commercializing, developing, and selling APT's catheters and related products, as well as achieving anticipated benefits without disrupting existing relationships with customers, suppliers, and employees. Suppliers mentioned include APT and Stereotaxis.

Stereotaxis Inc's Comment on Supply Chain


The company subcontracts all or part of the manufacturing and assembly of components for its products and devices. It faces risks including quality issues and manufacturing delays at its own facilities or those of subcontractors, which could affect revenue. The company may need to improve or modify product designs or subcontractor production processes to meet customer performance requirements. Efforts to upgrade and expand manufacturing, assembly, and testing capabilities may involve substantial costs and unexpected delays. The company recently completed the acquisition of APT, which previously operated independently and produced different products. Successful integration of APT depends on manufacturing, commercializing, developing, and selling APT's catheters and related products, as well as achieving anticipated benefits without disrupting existing relationships with customers, suppliers, and employees. Suppliers mentioned include APT and Stereotaxis.







STXS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Stereotaxis Inc 140.04 29.89 -22.32 131
SUBTOTAL 0.00 0.00 0.00 -


Sources: Stereotaxis Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Stereotaxis Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.